Brief: Cereno Scientific Drug Candidate Cs014 Completes First Part Of Phase I Trial

Cereno Scientific AB

11/02/2025 07:33

Feb 11 (Reuters) - Cereno Scientific AB  CRNOSb.ST :
    * DRUG CANDIDATE CS014 HAS COMPLETED FIRST PART OF PHASE I
TRIAL
IN HEALTHY VOLUNTEERS WITHOUT ANY SAFETY CONCERNS
    * PART TWO OF TRIAL (MAD) IS CURRENTLY ONGOING ACCORDING TO
PLAN
    * PHASE I TRIAL SEEN TO BE COMPLETED IN MID-2025

Source text: Link
Further company coverage:  CRNOSb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))